Sign In
Buy BCLI
$0.90
-0.0180 (-1.96%)
At Close: Jul 31, 2026
Longeveron Seeks $25 Million IPO For Anti-Aging Efforts
01:54pm, Friday, 05'th Feb 2021
Longeveron Seeks $25 Million IPO For Anti-Aging Efforts
Why Infinity Pharma, Meridian Bio, More Biotech Stocks Are Moving Today
12:34pm, Friday, 05'th Feb 2021
Infinity Pharmaceuticals (NASDAQ: INFI) shares are trading higher Friday after JPMorgan upgraded the stock from Underweight to Neutral. Infinity Pharmaceuticals is a clinical-stage biopharmaceutical c
Why BrainStorm Cell Therapeutics Blasted 27.7% Higher Today
06:31pm, Thursday, 04'th Feb 2021
The company isn't giving up on a promising pipeline drug.
Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q4 2020 Results - Earnings Call Transcript
04:05pm, Thursday, 04'th Feb 2021
Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q4 2020 Results - Earnings Call Transcript
NEW YORK, Jan. 20, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today the peer-revi
BrainStorm Issues 2020 Letter to Shareholders
07:00am, Monday, 28'th Dec 2020
NEW YORK, Dec. 28, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the following letter
BrainStorm Announces Completion of All Dosing in NurOwn® Phase 2 MS Study
07:00am, Friday, 18'th Dec 2020
NEW YORK, Dec. 18, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today that all dosi
Hedge Funds Aren't Crazy About Brainstorm Cell Therapeutics Inc. (BCLI) Anymore
11:36pm, Thursday, 26'th Nov 2020
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investmen
Brainstorm Cell Therapeutics News: 8 Things for BCLI Stock Investors to Know About the ALS Study
12:42pm, Tuesday, 17'th Nov 2020
Brainstorm Cell Therapeutics (BCLI) news for Tuesday has BCLI stock taking a beating following results from its ALS study. The post Brainstorm Cell Therapeutics News: 8 Things for BCLI Stock Investors
Why BrainStorm Cell Therapeutics Stock Imploded Today
12:31pm, Tuesday, 17'th Nov 2020
The company reported disappointing results from a pivotal clinical trial.
BrainStorm Announces Topline Results from NurOwn® Phase 3 ALS Study
07:30am, Tuesday, 17'th Nov 2020
NEW YORK, Nov. 17, 2020 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced today topline resul
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 14)
10X Genomics Inc (NASDAQ:...
PlusDental expandiert nach Frankreich und ist Deutschlands Testsieger
12:00am, Thursday, 08'th Oct 2020
Plusdental expandiert im Rahmen seines Wachstumskurses in den französischen Markt und ist nun in insgesamt sechs europäischen Ländern vertreten. Das B
Sabio Group erweitert mit der Übernahme von Anana ihre Kompetenzen in Kundenerfahrung
12:00am, Tuesday, 06'th Oct 2020
Sabio Group hat den Spezialisten für Kundenerfahrungslösungen Anana erworben. Die Übernahme unterstützt das Ziel von Sabio, zum führenden Anbieter auf
